FIELD: pharmacy. SUBSTANCE: composition is a lyophilizate obtained from an aqueous solution containing interferon (1-6.6) x 106 IU; sodium chloride 8.5-9.05 mg; partially hydrolyzed dextran (molecular mass is 60 ± 10 kDa) 5-30 mg, and buffer mixture up to pH value of solution 7.0-7.6 (as measured for 1 ml). Preferably, polyglucin and phosphate mixture were used as dextran and buffer, respectively. Composition is used for preparing drugs used for viral infection treatment (injection solutions, intranasal aerosols, eye drops and others). EFFECT: enhanced effectiveness of composition. 3 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PREPARATION BASED UPON HUMAN RECOMBINANT ALPHA-2-INTERFERON FOR INJECTIONS IN DRY LYOPHILIZED FORM | 2002 |
|
RU2236866C2 |
| COMPOSITION CONTAINING HUMAN RECOMBINANT INTERFERON ALPHA-2b, AND MEDICINAL AGENT OF PROLONGED ACTION FOR VETERINARY SCIENCE ON ITS BASIS, HAVING ANTIVIRUS AND IMMUNOMODULATORY ACTION | 2009 |
|
RU2404797C1 |
| COMPOSITION CONTAINING HUMAN RECOMBINANT INTERFERON ALPHA-2b, AND MEDICINAL AGENT OF PROLONGED ACTION FOR VETERINARY SCIENCE ON ITS BASIS, HAVING ANTIVIRUS, IMMUNOMODULATORY AND ANTIBACTERIAL ACTION | 2009 |
|
RU2404798C1 |
| HUMAN INTERFERON-ALPHA-TWO AQUEOUS SOLUTION FOR INJECTION | 2002 |
|
RU2238758C2 |
| LIPOSOMAL PERORAL ANTIVIRAL TREATMENT-AND-PROPHYLACTIC AGENT ON BASIS OF HUMAN INTERFERON ALPHA | 2008 |
|
RU2361572C1 |
| COMPOSITION OF AQUEOUS SOLUTION OF RECOMBINANT HUMAN INTERFERON ALPHA-2 FOR RECTAL ADMINISTRATION | 2014 |
|
RU2564951C1 |
| INTERFERON PREPARATION | 2001 |
|
RU2218934C2 |
| IMMUNOMODULATING PREPARATION "NEOFERON" SHOWING ANTIVIRAL ACTIVITY | 1996 |
|
RU2129878C1 |
| ZINC-CONTAINING AEROSOL COMPOSITION | 2009 |
|
RU2410082C1 |
| ANTIVIRAL AGENT - NASAL DROPS "GRIPPFERON" | 1999 |
|
RU2140285C1 |
